Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Aug 24:6:7.
doi: 10.1186/1475-2883-6-7.

Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience

Affiliations

Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience

B Nandha et al. Filaria J. .

Abstract

Background: The recommended strategy for elimination of Lymphatic filariasis is single-dose, once-yearly mass treatment with anti-filarial drugs and the program is in operation on a national level in India. Rate of coverage and consumption is the most crucial factor in the success of Mass Drug Administration (MDA) program. In spite of massive efforts, the program demonstrated sub-optimal coverage and consumption in urban areas than rural. The involvement of Anganwadi workers (AWWs) of the Integrated Child Development Scheme (ICDS) as communicators and drug distributors was attempted to enhance the coverage and consumption in urban areas and the results presented here.

Methods: An annual single dose MDA program was launched under the auspices of Freedom From Filariasis (FFF) program in Pondicherry, India, in the year 1997 and continued for five years. A questionnaire survey was carried out following all the treatment rounds (TRs) for assessing coverage of distribution and consumption Five percent of randomly selected households constituted the sample. All the members available in the selected household at the time of interview formed the respondent of the study.

Results: The coverage of drug distribution during the TRs varied from 74.3 to 95.4 percent and consumption rate from 52.9 to 78.8. Among the respondents, 71% were aware of the MDA program and the source of information for 62.8% of them was through personal communication by the AWW. It was observed that 33.2% of the respondents who accepted the drug did so based on the trust on the AWW as a government representative. The main reason for non-consumption in all TRs was fear of side reaction (25.4 - 42.2%).

Conclusion: The delivery-strategy of health information and Diethylcarbamazine (DEC) drug to the urban community using the AWWs could achieve relatively higher coverage and consumption than reported in other urban areas. In order to achieve the optimum level, it is imperative to equip the AWWs with current knowledge and skills, and design innovative Information, Education and Communication (IEC) campaign to target the less compliant groups. The beneficial effect of this delivery strategy may be used in similar urban settings to achieve the elimination of LF.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Coverage of DEC drug distribution and consumption in different rounds of treatment.

References

    1. World Health organization Global Program to Eliminate Lymphatic Filariasis. Wkly Epidemiol Rec. 2006;81:221–232. - PubMed
    1. Molyneux DH, Zagaria N. Lymphatic filariasis elimination: progress in global program development. Ann Trop Med Parasitol. 2002;96:S15–40. doi: 10.1179/000349802125002374. - DOI - PubMed
    1. WHO Lymphatic filariasis: progress of disability prevention activities. Weekly epidemiological record. 2004;79:417–24. - PubMed
    1. Molyneux DH, Taylor MJ. Current status and future prospects of the Global Lymphatic Filariasis program. Curr Opin Infect Dis. 2001;14:155–59. doi: 10.1097/00001432-200104000-00008. - DOI - PubMed
    1. Gyapong JO, Kumaraswami V, Biswas G, Ottessen EA. Treatment strategies underpinning the global program to eliminate Lymphatic Filariasis. Expert Opinion on Pharmacotherapy. 2005;6:179–200. doi: 10.1517/14656566.6.2.179. - DOI - PubMed